Log in

Relevant bibliographies by topics / Radiolabeled peptide

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'Radiolabeled peptide'

Author: Grafiati

Published: 14 March 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Radiolabeled peptide.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Radiolabeled peptide"

1

Farzipour, Soghra, and Seyed Jalal Hosseinimehr. "Correlation between in vitro and in vivo Data of Radiolabeled Peptide for Tumor Targeting." Mini-Reviews in Medicinal Chemistry 19, no. 12 (2019): 950–60. http://dx.doi.org/10.2174/1389557519666190304120011.

Full text

Abstract:

Tumor-targeting peptides have been generally developed for the overexpression of tumor specific receptors in cancer cells. The use of specific radiolabeled peptide allows tumor visualization by single photon emission computed tomography (SPECT) and positron emission tomography (PET) tools. The high affinity and specific binding of radiolabeled peptide are focusing on tumoral receptors. The character of the peptide itself, in particular, its complex molecular structure and behaviors influence on its specific interaction with receptors which are overexpressed in tumor. This review summarizes var

APA, Harvard, Vancouver, ISO, and other styles

2

Lo, Wei-Lin, Shih-Wei Lo, Su-Jung Chen, et al. "Molecular Imaging and Preclinical Studies of Radiolabeled Long-Term RGD Peptides in U-87 MG Tumor-Bearing Mice." International Journal of Molecular Sciences 22, no. 11 (2021): 5459. http://dx.doi.org/10.3390/ijms22115459.

Full text

Abstract:

The Arg–Gly–Asp (RGD) peptide shows a high affinity for αvβ3 integrin, which is overexpressed in new tumor blood vessels and many types of tumor cells. The radiolabeled RGD peptide has been studied for cancer imaging and radionuclide therapy. We have developed a long-term tumor-targeting peptide DOTA-EB-cRGDfK, which combines a DOTA chelator, a truncated Evans blue dye (EB), a modified linker, and cRGDfK peptide. The aim of this study was to evaluate the potential of indium-111(111In) radiolabeled DOTA-EB-cRGDfK in αvβ3 integrin-expressing tumors. The human glioblastoma cell line U-87 MG was u

APA, Harvard, Vancouver, ISO, and other styles

3

Persidis, A., A. A. Harcombe, A. P. Davenport, R. E. Kuc, C. Plumpton, and P. L. Weissberg. "Isolation of Human Cardiac Endothelin Receptors by a Peptide-Receptor Mobility Shift Assay." Clinical Science 85, no. 2 (1993): 169–73. http://dx.doi.org/10.1042/cs0850169.

Full text

Abstract:

1. A peptide-protein mobility shift assay has been developed, using native polyacrylamide-gel electrophoresis, that enables the isolation of de-natured receptor proteins from small amounts of human cardiac tissue. 2. Radiolabeled endothelin-1 and related peptides were used to identify and isolate endothelin receptors from partially purified membrane extracts of human atrial tissue. 3. Binding analysis using radiolabelled endothelin-1 gave an equilibrium dissociation constant (Kd) of 2 nmol/l, similar to results from binding experiments conducted directly on tissue. 4. Peptide-receptor complexe

APA, Harvard, Vancouver, ISO, and other styles

4

Mansi, Rosalba, Berthold A. Nock, Simone U. Dalm, Martijn B. Busstra, Wytske M. van Weerden, and Theodosia Maina. "Radiolabeled Bombesin Analogs." Cancers 13, no. 22 (2021): 5766. http://dx.doi.org/10.3390/cancers13225766.

Full text

Abstract:

The gastrin-releasing peptide receptor (GRPR) is expressed in high numbers in a variety of human tumors, including the frequently occurring prostate and breast cancers, and therefore provides the rationale for directing diagnostic or therapeutic radionuclides on cancer lesions after administration of anti-GRPR peptide analogs. This concept has been initially explored with analogs of the frog 14-peptide bombesin, suitably modified at the N-terminus with a number of radiometal chelates. Radiotracers that were selected for clinical testing revealed inherent problems associated with these GRPR ago

APA, Harvard, Vancouver, ISO, and other styles

5

Zhang, Yifan, and Wengen Chen. "Radiolabeled glucagon-like peptide-1 analogues." Nuclear Medicine Communications 33, no. 3 (2012): 223–27. http://dx.doi.org/10.1097/mnm.0b013e32834e7f47.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Zavvar, Taraneh Sadat, Anton Amadeus Hörmann, Maximilian Klingler, et al. "Effects of Side Chain and Peptide Bond Modifications on the Targeting Properties of Stabilized Minigastrin Analogs." Pharmaceuticals 16, no. 2 (2023): 278. http://dx.doi.org/10.3390/ph16020278.

Full text

Abstract:

Different attempts have been made in the past two decades to develop radiolabeled peptide conjugates with enhanced pharmacokinetic properties in order to improve the application for tumor imaging and peptide receptor radionuclide therapy (PRRT), which targets the cholecystokinin-2 receptor (CCK2R). In this paper, the influence of different side chain and peptide bond modifications has been explored for the minigastrin analog DOTA-DGlu-Ala-Tyr-Gly-Trp-(N-Me)Nle-Asp-1Nal-NH2 (DOTA-MGS5). Based on this lead structure, five new derivatives were synthesized for radiolabeling with trivalent radiomet

APA, Harvard, Vancouver, ISO, and other styles

7

Ducharme, Maxwell, Hailey A. Houson, Solana R. Fernandez, and Suzanne E. Lapi. "Evaluation of 68Ga-Radiolabeled Peptides for HER2 PET Imaging." Diagnostics 12, no. 11 (2022): 2710. http://dx.doi.org/10.3390/diagnostics12112710.

Full text

Abstract:

One in eight women will be diagnosed with breast cancer in their lifetime and approximately 25% of those cases will be HER2-positive. Current methods for diagnosing HER2-positive breast cancer involve using IHC and FISH from suspected cancer biopsies to quantify HER2 expression. HER2 PET imaging could potentially increase accuracy and improve the diagnosis of lesions that are not available for biopsies. Using two previously discovered HER2-targeting peptides, we modified each peptide with the chelator DOTA and a PEG2 linker resulting in DOTA-PEG2-GSGKCCYSL (P5) and DOTA-PEG2-DTFPYLGWWNPNEYRY (

APA, Harvard, Vancouver, ISO, and other styles

8

Klingler, Maximilian, Anton Amadeus Hörmann, and Elisabeth Von Guggenberg. "Cholecystokinin-2 Receptor Targeting with Radiolabeled Peptides: Current Status and Future Directions." Current Medicinal Chemistry 27, no. 41 (2020): 7112–32. http://dx.doi.org/10.2174/0929867327666200625143035.

Full text

Abstract:

A wide variety of radiolabeled peptide analogs for specific targeting of cholecystokinin- 2 receptors (CCK2R) has been developed in the last decades. Peptide probes based on the natural ligands Minigastrin (MG) and Cholecystokinin (CCK) have a high potential for molecular imaging and targeted radiotherapy of different human tumors, such as Medullary Thyroid Carcinoma (MTC) and Small Cell Lung Cancer (SCLC). MG analogs with high persistent uptake in CCK2R expressing tumors have been preferably used for the development of radiolabeled peptide analogs. The clinical translation of CCK2R targeting

APA, Harvard, Vancouver, ISO, and other styles

9

Şenışık, Ahmet M., Çiğdem İçhedef, Ayfer Y. Kılçar, et al. "Evaluation of New 99mTc(CO)3 + Radiolabeled Glycylglycine In Vivo." Anti-Cancer Agents in Medicinal Chemistry 19, no. 11 (2019): 1382–87. http://dx.doi.org/10.2174/1871520619666190404154723.

Full text

Abstract:

Background: Peptide-based agents are used in molecular imaging due to their unique properties, such as rapid clearance from the circulation, high affinity and target selectivity. Many of the radiolabeled peptides have been clinically experienced with diagnostic accuracy. The aim of this study was to investigate in vivo biological behavior of [99mTc(CO)3(H2O)3]+ radiolabeled glycylglycine (GlyGly). Methods: Glycylglycine was radiolabeled with a high radiolabeling yield of 94.69±2%, and quality control of the radiolabeling process was performed by thin layer radiochromatography (TLRC) and High-P

APA, Harvard, Vancouver, ISO, and other styles

10

Mansi, Rosalba, and Melpomeni Fani. "Radiolabeled Peptides for Cancer Imaging and Therapy: From Bench-to-Bedside." CHIMIA International Journal for Chemistry 75, no. 6 (2021): 500–504. http://dx.doi.org/10.2533/chimia.2021.500.

Full text

Abstract:

Radiolabeled peptides can deliver radiation selectively to tumors via targeting peptide receptors that are overexpressed on the surface of cancer cells. The radiation is used either for detection (imaging) or for destruction (therapy) of these tumors. The Division of Radiopharmaceutical Chemistry at the University Hospital Basel has conducted pioneering work on the development of peptide-based radiopharmaceuticals. Our research covers the entire spectrum of such developments, from bench-to-bedside, and it is illustrated in this article by selective cases.

APA, Harvard, Vancouver, ISO, and other styles

Dissertations / Theses on the topic "Radiolabeled peptide"

1

Mandarini, Elisabetta. "Decoding the role of HSPGs in tumor onset and progression through use of branched peptide probe." Doctoral thesis, Università di Siena, 2020. http://hdl.handle.net/11365/1094789.

Full text

Abstract:

Heparan sulfate Proteoglycans (HSPGs) play a number of signaling and structural roles in tumor progression and metastasis spread. The biological function of HSPGs resides in their ability of interaction with many different types of ligands like growth factors, morphogens, chemokines and proteins of extracellular matrix (ECM). These bindings activate signaling pathways that modulate major transformations of cancer cells, leading to tumor growth, migration, invasion and metastasis. HSPGs are over-expressed on cancer cell membranes. The tetra-branched peptide NT4 binds with high selectivity to di

APA, Harvard, Vancouver, ISO, and other styles

2

Retzloff, Lauren Brooke Smith Charles J. "Design, synthesis, and evaluation of radiolabeled bombesin conjugates for the diagnosis of breast cancer." Diss., Columbia, Mo. : University of Missouri-Columbia, 2009. http://hdl.handle.net/10355/6740.

Full text

Abstract:

The entire dissertation/thesis text is included in the research.pdf file; the official abstract appears in the short.pdf file (which also appears in the research.pdf); a non-technical general description, or public abstract, appears in the public.pdf file. Title from PDF of title page (University of Missouri--Columbia, viewed on March 25, 2010). Vita. Thesis advisor: Charles J. Smith. "December 2009" Includes bibliographical references.

APA, Harvard, Vancouver, ISO, and other styles

3

Dean, Kevin Raymond. "The synthesis and properties of radiolabelled melittin derivatives." Thesis, University of Essex, 1990. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.278536.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Pourghiasian, Maral. "Novel radiolabeled peptides to improve breast and prostate cancer diagnosis by PET." Thesis, University of British Columbia, 2015. http://hdl.handle.net/2429/52671.

Full text

Abstract:

In the past years, peptide based radiopharmaceuticals have turned into favorable molecular imaging agents for specific targeting of cancer. This is mainly because many tumors happen to overexpress certain regulatory peptide receptors. For instance, the gastrin releasing peptide (GRP) receptors are overexpressed in prostate cancer–the most common malignancy among men–and somatostatin 2a (SST2a), and neuropeptide Y1 (NPY1) receptors are overexpressed in breast cancer–the most common cancer among women. There are disadvantages to most existing imaging techniques used for early detection of prost

APA, Harvard, Vancouver, ISO, and other styles

5

Amouroux, Guillaume Paul Victor. "PET/CT imaging of the human bradykinin 1 receptor using radiolabeled peptides for cancer detection." Thesis, University of British Columbia, 2016. http://hdl.handle.net/2429/58956.

Full text

Abstract:

Many compounds mimicking endogenous molecules have been used as a starting point to develop targeted diagnostic and therapeutic radiotracers. In particular, radiolabeled peptidomimetics, in association with positron emission tomography combined with computed tomography (PET/CT), are powerful tools to detect cancer with high sensitivity. Peptide-based radiotracers have the advantage of combining favorable pharmacokinetics that allow the use of short-lived isotopes, with a flexible modular design that offers a high versatility for functionalization, making them optimal for developing targeted im

APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Radiolabeled peptide"

1

IAEA. Clinical Translation of Radiolabelled Monoclonal Antibodies and Peptides. International Atomic Energy Agency, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

International Atomic Energy Agency (IAEA). Clinical Translation of Radiolabelled Monoclonal Antibodies and Peptides: IAEA Human Health Series No. 8. International Atomic Energy Agency, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Radiolabeled peptide"

1

Buscombe, John. "Peptide Receptor Radionuclide Therapy Using Radiolabeled Somatostatin Analogues." In Somatostatin Analogues. John Wiley & Sons, Inc, 2015. http://dx.doi.org/10.1002/9781119031659.ch19.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Luyt, Leonard G. "The Design of Radiolabeled Peptides for Targeting Malignancies." In Monoclonal Antibody and Peptide-Targeted Radiotherapy of Cancer. John Wiley & Sons, Inc., 2010. http://dx.doi.org/10.1002/9780470613214.ch3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Flanagan, Richard J. "Radiolabeled Atrial Natriuretic Peptide and Somatostatin for in Vivo Imaging of Receptors." In Nuclear Imaging in Drug Discovery, Development, and Approval. Birkhäuser Boston, 1993. http://dx.doi.org/10.1007/978-1-4684-6808-3_13.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Luca, Stefania De, Annarita Del Gatto, Menotti Ruvo, et al. "A new and selective radiolabeled αVβ3 peptide antagonist as tracer in tumor diagnosis." In Advances in Experimental Medicine and Biology. Springer New York, 2009. http://dx.doi.org/10.1007/978-0-387-73657-0_189.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Dean, R. T., J. L. -James, R. S. Lees, A. M. Lees, S. Vallabhajosula, and S. J. Goldsmith. "Peptides in Biomedical Sciences: Principles and Practice." In Radiolabeled Blood Elements. Springer US, 1994. http://dx.doi.org/10.1007/978-1-4615-2462-5_29.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Thakur, M. L. "Peptides and Proteins in Radiolabeling of Blood Elements." In Radiolabeled Blood Elements. Springer US, 1994. http://dx.doi.org/10.1007/978-1-4615-2462-5_28.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Knight, Linda C. "Radiolabeled Peptides for Tumor Imaging." In Handbook of Radiopharmaceuticals. John Wiley & Sons, Ltd, 2005. http://dx.doi.org/10.1002/0470846380.ch23.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Benedetti, Ettore, Giancarlo Morelli, Raffaella Della Moglie, et al. "Radiolabeled Peptides as CXCR4 Ligands." In Understanding Biology Using Peptides. Springer New York, 2006. http://dx.doi.org/10.1007/978-0-387-26575-9_75.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Bodei, Lisa, Laura Gilardi, Duccio Volterrani, et al. "Neuroendocrine Tumors: Therapy with Radiolabeled Peptides." In Nuclear Oncology. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-26067-9_50-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Bodei, Lisa, Laura Gilardi, Duccio Volterrani, et al. "Neuroendocrine Tumors: Therapy with Radiolabeled Peptides." In Nuclear Oncology. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-26236-9_50.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Radiolabeled peptide"

1

Evangelou, Alexia, Christos Zikos, Dimitra Benaki, et al. "In vitro and in vivo studies of the neuroprotective peptide humanin using 125I-radiolabeled humanin derivatives." In XIth Conference Biologically Active Peptides. Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, 2009. http://dx.doi.org/10.1135/css200911034.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Nievelstein, P. F. E. M., M. Ottenhof-Rovers, M. D. Pierschbacher, and J. J. Sixma. "THE ARG-GLY-ASP(SER) SEQUENCE OF FIBRONECTIN, AND THE GLYCOPROTEIN IIB-IIIA COMPLEX ARE NOT INVOLVED IN FIBRONECTIN DEPENDENT PLATELET ADHESION IN FLOW." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643590.

Full text

Abstract:

Activated blood platelets interact with fibronectin through it to the glycoprotein IIb-IIIa(GPIIb-IIIa)-complex. The cell attachment site of fibronectin with its crucial arg-gly-asp-(-ser) (RGD(S))sequence is involved in this binding. We have studied the importance of this interaction for the fibronectin dependence of platelet adhesion under flow conditions. An RGDS-containing hexapeptide (GRGDSP) was compared with a non-reactive control peptide (GRGESP). The GRGDSP-peptide inhibited thrombin induced aggregation and adhesion under static conditions at 0.1 mM. This concentration had no effect o

APA, Harvard, Vancouver, ISO, and other styles

3

Berrettini, M., M. J. Heeb, and J. H. Griffin. "ISOLATION AND FUNCTIONAL PROPERTIES OF MONOMERIC BLOOD COAGULATION FACTOR XI." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1642803.

Full text

Abstract:

To evaluate the significance of the normal dimeric structure (160,000 MW) of blood coagulation Factor XI (F.XI), a monomeric form (80,000 MW) was produced by mild reduction and alkylation of native F.XI. Since initial efforts to reduce and alkylate F.XI in solution inactivated the molecule, F.XI was bound to high MW kininogen (HMWK) to stabilize the native structure. Purified F.XI was bound to HMWK-Sepharose, and the column was washed for 2 h with 40 μM dithiothreitol in 4mM acetate buffer, 2mM EDTA, 1mM benzamidine, pH 7.8, and then for 2 h with 50 μM iodoacetamide in the same buffer. Elution

APA, Harvard, Vancouver, ISO, and other styles

4

Colman, R. W., A. Gewirtz, D. L. Wang, et al. "BIOSYNTHESIS AND EXPRESSION OF FACTOR V IN MAGAKARYOCYTES." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1642955.

Full text

Abstract:

Coagulation factor V (FV), is a single chain, multifunctional glycoprotein of Mr 350,000 which interacts with a variety of hemostatic proteins such as factor Xa, prothrombin, thrombin and protein C, on the surface of platelets and vascular endothelial cells. FV serves as both a cofactor and substrate in the generation of thrombin and plays a critical regulatory role in both physiologic hemostasis and pathologic thrombosis. The biosynthesis of FV and its subsequent expression are therefore expected to be precisely controlled and may differ in the three sites of synthesis - hepatocytes, endothel

APA, Harvard, Vancouver, ISO, and other styles

5

Hantgan, R. R. "LOCALIZATION OF THE DOMAINS OF FIBRIN INVOLVED IN BINDING TO PLATELETS." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643773.

Full text

Abstract:

The molecular basis of platelet-fibrin interactions has been investigated by using synthetic peptides as potential inhibitors of binding fibrin protofibrils and fibrinogen to ADP-stimulated platelets, adhesion of fibrin fibers to the platelet surface, and platelet-mediated clot retraction. Synthetic peptides RGDS and HHLGGAKQAGDV, corresponding to regions of the fibrinogen α and γ chains previously identified as platelet recognition sites, inhibited the binding of radiolabelled soluble fibrin oligomers to ADP-stimulated platelets with IC50 values of 12 and 40 μM, respectively. The IC50 values

APA, Harvard, Vancouver, ISO, and other styles

6

Minno, G. Di, A. M. Cerbone, F. Cirillo, et al. "ABNORMAL FIBRINOGEN (FIBRINOGEN NAPLES) CHARACTERIZED BY DETECTIVE INTERACTION WITH THROMBIN AND PLASMIN IN TWO YOUNG SIBLINGS WITH ARTERIAL THROMBOSIS." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644698.

Full text

Abstract:

Prolonged thrombin time (partially corrected by calcium chloride) and normal reptilase time were found in the plasma of two siblings with arterial thrombosis. Their purified fibrinogen showed similar abnormalities as well as impaired fibrino-peptide release in response to thrombin, delayed polymerization of pre-formed fibrin monomers and normal sialic content. Binding of radiolabelled thrombin by patient's fibrin was 30% of normal. Supernatants from patients' fibrin clots contained abnormal amounts of thrombin (not adsorbed by fibrin) and caused abnormal enhancement of platelet aggregation and

APA, Harvard, Vancouver, ISO, and other styles

7

Bode, A. P., D. T. Miller, and S. Newman. "GENERATION OF COMPLEMENT ACTIVATION PEPTIDES DURING STORAGE OF PLATELET CONCENTRATES (PC)." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644689.

Full text

Abstract:

Platelets are routinely stored for transfusion at room temperature in autologous, citrated plasma. We have demonstrated previously that these conditions do not completely block activation of plasma enzyme systems, as indicated by generation of thrombin activity (Vox Sanguinis, JL1:192,1986). Here, we demonstrate the conversion of large amounts of complement factor C3 during storage of citrated PC by using radioimmunoassay quantitation of the activation peptide C3a des-Arg (Upjohn Diagnostics). Supernatant samples from stored PC and from citrated platelet-poor plasma (PPP) stored under the same

APA, Harvard, Vancouver, ISO, and other styles

8

Church, W., T. Messier, P. Howard, J. Amiral, D. Meyer, and K. Mam. "A SHARED EPITOPE ON HUMAN PROTEIN C, FACTOR X, FACTOR VII, AND PROTTOBIN DEFINED BY A MONOCLONAL ANTIBODY." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643937.

Full text

Abstract:

A monoclonal antibody prepared against hunan protein C (HPC) was found to react with several other vitamin K-dependent blood proteins. Using a competitive inhibition solid-phase radioinminoassay with HPC, binding of 125I-HPC to the antibody was inhibited by purified prothrombin, Factor X, and Factor VII in addition to protein C. Other vitamin K-dependent proteins including Factor IX, protein S, and bone-GLA protein did not compete for binding of 125I-HPC to the antibody. The effect of calciun ion on the binding of antibody to 125I-HPC was examined in a solid-phase imnunoassay system with the a

APA, Harvard, Vancouver, ISO, and other styles

9

Preissner, K. T., E. Anders, and G. Müller-Berghaus. "INTERACTION OF S PROTEIN/VITRONECTIN WITH CULTURED ENDOTHELIAL CELLS: PROMOTION OF ATTACHMENT AND SPECIFIC BINDING." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643635.

Full text

Abstract:

The interaction of the complement inhibitor S protein, which is identical to the serum spreading factor, vitronectin, with cultured human endothelial cells of macro- and microvas- cular origin was investigated. Purified S protein, coated for 2 h on polystyrene petri dishes, induced concentration- and time-dependent attachment and spreading of human umbilical vein endothelial cells (HUVEC) as well as human omental tissqe microvasular endothelial cells (HOTMEC) at 37°C. With 3 × 105 cells/ml (final concentration) more than 50% of the cells attached within 2 h incubation at 0.3 - 3 μg/ml S protei

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Radiolabeled peptide"

1

Deutscher, Susan. Radiolabeled Peptide Scaffolds for PET/SPECT - Optical in Vivo Imaging of Carbohydrate-Lectin Interactions. Office of Scientific and Technical Information (OSTI), 2014. http://dx.doi.org/10.2172/1158790.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Rogers, Buck E. Induction of Human Somatostatin Receptor Subtype 2 on Breast Tumors with an Adenoviral Vector for Their Treatment and Detection with a Radiolabeled Peptide. Defense Technical Information Center, 2002. http://dx.doi.org/10.21236/ada409493.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Line, Bruce R., Antonio Passaniti, Carol Lambert, and Ron Mease. Evaluation of Radiolabeled Tumor Vessel Targeting Peptides as Novel Agents for the Staging and Therapy of Human Prostate Cancer. Defense Technical Information Center, 2002. http://dx.doi.org/10.21236/ada406974.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!